Committees

Drug Development

icon_globe Committee Website 

 icom_facebook  Facebook Page

 

In vivo imaging in the 21st century is increasingly being performed with significant industrial collaborations between Pharmaceutical companies and academic and healthcare providers. This is a mutually beneficial situation which can enable in vivo imaging in ways previously unimaginable. The Drug Development Interest Group is a springboard for those of you interested in engaging and finding out more about these activities. The field is multidisciplinary in nature, covering a gamut of activities including synthetic and medicinal chemistry, biology, pharmacology, pharmacokinetics/dynamics, clinical sciences, technology and instrumentation, mathematical modelling and physics.

Committee Chairpersons


Chair & Scientific Programme Representative

J. Vercouillie (France)

Committee Members


ESMIT Representative

W. Deuther-Conrad (Germany)

Secretary

L. Zimmer (France)

Scientific Programme Representative 2

G. Smith (United Kingdom)

Guideline Representative

G. Luurtsema (Netherlands)

Website Representative

L. Aloj (UK)

Communication, Press & PR Representative

Y. Seimbille (Netherlands)

Senior Advisor

A. Gee (UK)

This website uses cookies. Learn more